Marathon Oil is a restructuring story and is cheap compared to fellow North American E&P players, said Thomas Forester, portfolio manager for the Forester Value Fund. Forester added that Marathon is still immensely profitable even with oil prices moderating. Forester is also bullish on Amgen, saying the biotech powerhouse has a full pipeline and is under less pressure from biologic competition than Wall Street originally predicted. Finally, Forester is positive on J.C. Penney, stating that the retailer has turned itself around and it’s stock does not have to move very far to become a tremendously profitable investment.

More from Video

Why Jim Cramer Isn't Surprised By the Jobs Report

Why Jim Cramer Isn't Surprised By the Jobs Report

What to Expect From the Markets in 2019 According to an Abbott Downing Executive

What to Expect From the Markets in 2019 According to an Abbott Downing Executive

Facebook Could See More Volatility -- How to Own the Stock

Facebook Could See More Volatility -- How to Own the Stock

Facebook 'Needs to Fire' Sheryl Sandberg Says Jim Cramer

Facebook 'Needs to Fire' Sheryl Sandberg Says Jim Cramer

Trading Strategies: Understanding the Markets Going Into 2019

Trading Strategies: Understanding the Markets Going Into 2019